MDS
Clinical trials for MDS explained in plain language.
Never miss a new study
Get alerted when new MDS trials appear
Sign up with your email to follow new studies for MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to stop leukemia return after transplant
Disease control Not yet recruitingThis study tests whether adding two drugs (SHR2554 and azacitidine) to standard chemotherapy before a stem cell transplant can lower the chance of leukemia coming back. It includes 160 people aged 15-60 with high-risk or relapsed acute leukemia or myelodysplastic syndromes. Parti…
Matched conditions: MDS
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 26, 2026 11:10 UTC
-
New drug cocktail before transplant shows promise for tough leukemias
Disease control Not yet recruitingThis study tests whether adding two drugs (SHR2554 and azacitidine) to standard chemotherapy before a stem cell transplant can help people with high-risk or relapsed/refractory acute leukemia or myelodysplastic syndromes (MDS). About 180 participants aged 15-60 will be randomly a…
Matched conditions: MDS
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 26, 2026 11:09 UTC
-
New combo therapy aims to tame High-Risk bone marrow cancer
Disease control Not yet recruitingThis early-phase trial tests a new two-drug combination (pacritinib plus azacitidine) in 25 people with moderate to very high risk myelodysplastic syndrome (MDS), a bone marrow disorder. The first part finds the safest dose; the second part checks how well the combination works a…
Matched conditions: MDS
Phase: PHASE1, PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 10:58 UTC